Kilitch Drugs (India) Balance Sheet
- Market cap
- ₹871 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹179.42 – ₹336.41
As of FY25, Kilitch Drugs (India) had total assets of ₹566 crore and borrowings of ₹105 crore, against shareholders' equity of ₹512 crore — a debt-to-equity ratio of 0.35.
Kilitch Drugs (India) balance sheet
As at each financial year end, newest first. H1 = half-year.
| Item | FY25 |
|---|---|
| Equity capital | 120 |
| Reserves | 392 |
| Borrowings | 105 |
| Other liabilities | 69.7 |
| Total liabilities | 566 |
| Fixed assets | 305 |
| Capital work in progress | 45 |
| Investments | 131 |
| Other assets | 131 |
| Total assets | 566 |
Balance sheet ratios
- Debt to equity
- 0.35
- Book value per share
- ₹87.44
Source: Company filings (consolidated), in ₹ crore. Data as of 9 October 2026. How this data is compiled.
Kilitch Drugs (India) balance sheet — frequently asked questions
What is the total debt of Kilitch Drugs (India)?
Kilitch Drugs (India) reported borrowings of ₹105 crore as of FY25.
What is Kilitch Drugs (India)'s debt-to-equity ratio?
Based on the FY25 balance sheet, Kilitch Drugs (India)'s debt-to-equity ratio is 0.35 — borrowings of ₹105 crore against equity capital and reserves of ₹512 crore.
What are Kilitch Drugs (India)'s total assets?
Kilitch Drugs (India)'s total assets were ₹566 crore as of FY25, including fixed assets of ₹305 crore and investments of ₹131 crore.
What is the book value per share of Kilitch Drugs (India)?
The book value per share of Kilitch Drugs (India) is ₹87.44, based on the latest reported balance sheet.
Same Data For Peers
Trade Kilitch Drugs (India) With ATS
Track KILITCH live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.